Summit Clinical Research acquires Houston Research Institute
05/01/25, 7:20 PM
Location
san antoniohoustonIndustry
biotechnology
health care
Summit Clinical Research has completed the acquisition of Houston Research Institute to enhance its capabilities in clinical trials. The move will deepen Summit's leadership team and drive growth in metabolic research. Summit is focused on advancing treatment options for patients by merging scientific expertise and execution. This acquisition supports their mission to innovate in complex therapeutic areas.
Company Info
Location
San Antonio, Texas, United States
Company info
Summit Clinical Research is a leading Integrated Research Organization (IRO) specializing in liver disease, obesity, and Alzheimer's Disease. With a network of 120 sites, Summit has consistently advanced clinical development by enrolling more than 50% of patients in global studies. The company focuses on partnerships that support drug development objectives. Summit aims to expand its impact in various therapeutic areas.